Aura Biosciences, Inc. (AURA)

Aura Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	67.84	59.52	31.69	41.06	121.58	149.06
Short-Term Investments	256	84.73	119.4	185.09	67.23	-
Cash & Short-Term Investments	323.84	144.24	151.09	226.15	188.81	149.06
Cash Growth	82.64%	-4.54%	-33.19%	19.78%	26.66%	757.03%
Other Current Assets	5.19	5.5	9.53	5.64	7.89	4.64
Total Current Assets	329.03	149.74	160.62	231.79	196.7	153.7
Net Property, Plant & Equipment	17.19	18.45	20.59	22	26.04	6.2
Other Long-Term Assets	1.91	1.24	1.29	1.28	1.19	0.13
Total Assets	348.13	169.43	182.5	255.08	223.94	160.03

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.25	1.55	2.3	1.79	2.92	2.4
Accrued Expenses	14.01	13.59	9.46	7.88	4.57	4.34
Current Portion of Leases	3.29	3.24	3.15	2.69	2.96	0.62
Total Current Liabilities	19.56	18.38	14.91	12.36	10.46	7.36
Long-Term Leases	13.3	14.13	15.62	16.87	17.9	0.36
Total Long-Term Liabilities	13.3	14.13	15.62	16.87	17.9	0.36
Total Liabilities	32.86	32.52	30.53	29.23	28.35	7.72

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Treasury Stock	-39.09	-	-	-	-	-
Additional Paid-in Capital	914.77	617.43	525.93	512.62	406.56	304.45
Accumulated Other Comprehensive Income	-0.67	-0.1	0.26	0.54	-0.07	-
Retained Earnings	-559.74	-480.42	-374.23	-287.31	-210.9	-152.14
Total Common Shareholders' Equity	354.36	136.91	151.97	225.85	195.58	152.32
Shareholders' Equity	354.36	136.91	151.97	225.85	195.58	152.32
Total Liabilities & Equity	348.13	169.43	182.5	255.08	223.94	160.03

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	16.59	17.38	18.77	19.56	20.86	0.98
Net Cash (Debt)	307.25	126.86	132.33	206.59	167.95	148.09
Net Cash Growth	93.00%	-4.13%	-35.95%	23.01%	13.41%	751.42%
Net Cash Per Share	4.16	2.10	2.67	5.21	5.61	28.70
Book Value	354.36	136.91	151.97	225.85	195.58	152.32
Book Value Per Share	4.80	2.27	3.06	5.70	6.53	29.52
Tangible Book Value	354.36	136.91	151.97	225.85	195.58	152.32
Tangible Book Value Per Share	4.80	2.27	3.06	5.70	6.53	29.52

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Aug 11, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 13, 2026

Data Sources Report a data error